EUVIMEDEUVIMED entdecken
Crossref

Oxygen-Generating Transdermal Nanoplatform Codelivering BRD4 Proteolysis-Targeting Chimera/Verteporfin/CaO 2 Synergistically Remodels Immunosuppressive Melanoma Microenvironment to Potentiate Combination Immunotherapy

Mingli Wei, Tian Yin, Chenxiao Chu, Muse Ji, Jiansong Zhao, Xinxin Liang, Xiaoshuang Bi, Jingxin Gou, Haibing He iD, Xing Tang iD, Yu Zhang iD

ACS Nano · 22.07.2025 · 19 (28) · 25830-25850

DOI: 10.1021/acsnano.5c04580 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 08.07.2025. Verfasst von Mingli Wei und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China. Hauptthemen laut MEDLINE: Immunotherapy, Nanoparticles, Oxygen, Verteporfin. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Department of Education of Liaoning Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyNanoparticlesOxygenVerteporfinMelanomaTranscription FactorsCalcium CompoundsCell Cycle ProteinsTumor MicroenvironmentAnimalsMiceHumansPhotosensitizing AgentsProteolysisOxidesPhotochemotherapyCell Line, TumorMelanoma, ExperimentalMice, Inbred C57BLReactive Oxygen SpeciesBromodomain Containing Proteins

Stichwörter der Autor:innen

epigenetic therapyhypoxia alleviationphotodynamic therapypostoperative managementproteolysis-targeting chimeratumor microenvironment

Substanzen

OxygenVerteporfinTranscription FactorsPhotosensitizing AgentsOxidesCalcium CompoundsBRD4 protein, humanCell Cycle ProteinslimeReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China.
  • School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China.

ORCID-Profile: Haibing He, Xing Tang, Yu Zhang

Förderung

  • National Key Research and Development Program of China
  • Department of Education of Liaoning Province
  • National Natural Science Foundation of China

Zitieren

APA

Wei, M., Yin, T., Chu, C., Ji, M., Zhao, J., Liang, X., Bi, X., Gou, J., He, H., Tang, X., & Zhang, Y. (2025). Oxygen-Generating Transdermal Nanoplatform Codelivering BRD4 Proteolysis-Targeting Chimera/Verteporfin/CaO 2 Synergistically Remodels Immunosuppressive Melanoma Microenvironment to Potentiate Combination Immunotherapy. ACS Nano, 19(28), 25830-25850. https://doi.org/10.1021/acsnano.5c04580

Vancouver

Wei M, Yin T, Chu C, Ji M, Zhao J, Liang X, et al. Oxygen-Generating Transdermal Nanoplatform Codelivering BRD4 Proteolysis-Targeting Chimera/Verteporfin/CaO 2 Synergistically Remodels Immunosuppressive Melanoma Microenvironment to Potentiate Combination Immunotherapy. ACS Nano. 2025;19(28):25830-25850. doi:10.1021/acsnano.5c04580

BibTeX
@article{Wei2025,
  author = {Wei, Mingli and Yin, Tian and Chu, Chenxiao and Ji, Muse and Zhao, Jiansong and Liang, Xinxin and Bi, Xiaoshuang and Gou, Jingxin and He, Haibing and Tang, Xing and Zhang, Yu},
  title = {Oxygen-Generating Transdermal Nanoplatform Codelivering BRD4 Proteolysis-Targeting Chimera/Verteporfin/CaO 2 Synergistically Remodels Immunosuppressive Melanoma Microenvironment to Potentiate Combination Immunotherapy},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {28},
  pages = {25830--25850},
  doi = {10.1021/acsnano.5c04580}
}
Kostenlos starten →